ClinicalTrials.Veeva

Menu
V

VITA LONGA Sp. z o.o. | Katowice, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elinzanetant
Vilaprisan
BI 456906
Rimegepant
BAY1817080
Cenerimod
BAY3427080
Vericiguat
Vicadrostat
VE202

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 23 total trials

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (OPUS-1)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Enrolling
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

This study consists of two parts: Part A Surveillance and Part B Transmission.The main purpose of Part A is to evaluate the prevalence of pre-dose an...

Enrolling
Influenza
Drug: Baloxavir Marboxil

The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe sympto...

Invitation-only
Lupus Erythematosus, Systemic
Drug: Cenerimod

Allergic rhinoconjunctivitis due to birch pollen is a seasonal problem which manifests as a combination of nasal symptoms (such as congestion, runny...

Active, not recruiting
Birch Pollen Allergy
Allergic Rhinoconjunctivitis
Drug: STALORAL® Birch 300 IR

Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational stu...

Enrolling
Disease Crohn
Crohn Disease
Biological: Vedolizumab

Trial sponsors

Bayer logo
Boehringer Ingelheim logo
Pfizer logo
V
A
Bridge Biotherapeutics logo
I
Kissei logo
Roche logo
Stallergenes Greer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems